Publication:
CD3(-)CD56(+) NK cells display an inflammatory profile in RR-MS patients

Placeholder

Organizational Units

Program

KU Authors

Co-Authors

Tahrali, İlhan
Küçüksezer, Umut Can
Akdeniz, Nilgün
Uygunoğlu, Uğur
Aktaş-Çetin, Esin
Deniz, Günnur

Advisor

Publication Date

Language

English

Journal Title

Journal ISSN

Volume Title

Abstract

Multiple Sclerosis (MS) is an immune-mediated and neurodegenerative disease of central nervous system. Relapsing-remitting (RR)-MS occurring with acute attacks and remissions, is the most common clinical type of MS. There are different strategies applied in first-line treatment of RR-MS patients such as interferon-beta (IFN-beta) and glatiramer acetate. In this study, activating and inhibitory receptor expressions and interleukin (IL)-22 levels of NK cells were investigated in RR-MS patients with or without IFN-beta therapy. Activating receptor expression and IL-22 levels of NK cells were increased in RR-MS patients under IFN-beta therapy. Elevated NK cells with activating profile and increased IL-22 under IFN-beta therapy suggest that IFN-beta treatment might direct NK cells toward a pro-inflammatory status.

Description

Source:

Immunology Letters

Publisher:

Elsevier

Keywords:

Subject

Immunology

Citation

Endorsement

Review

Supplemented By

Referenced By

Copy Rights Note

0

Views

0

Downloads

View PlumX Details